Clinical Trial Update: A Study With NLY01 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update for NLY01 in subjects with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NLY01

Snippet

Sponsor: Neuraly, Inc. | Conditions: Type2 Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED